<DOC>
	<DOCNO>NCT02555566</DOCNO>
	<brief_summary>Endothelial lesion within transplant kidney major determinant chronic allograft nephropathy . Epoxyeicosatrienoic acid ( EETs ) endothelium-derived hyperpolarizing factor anti-inflammatory , antiproliferative vasodilator property . The main goal investigator ' study evaluate whether genetic polymorphism specific enzyme responsible bioavailability EETs associate post-transplant kidney function . To end , 80 kidney transplant recipient include . Prespecified genetic polymorphism CYP 2J2 , CYP 2C8 , CYP 2C9 , CYP 2C9 , CYP 2C19 EPHX2 determine . Kidney function record 3 , 6 , 12 36 month transplantation . Flow-mediated dilatation , EETs circulate biomarkers endothelial function measure radial artery . The expected result study provide preliminary evidence support beneficial role increase bioavailability EETs kidney transplant recipient .</brief_summary>
	<brief_title>Role Epoxyeicosatrienoic Acids Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study</brief_title>
	<detailed_description />
	<criteria>Patient age 18 75 yo Caucasian ( different CYP epoxygenase polymorphism ) First kidney transplantation perform Rouen University Hospital 2000 , least 12 month inclusion Patient read , understood approve informed consent Efficient contraception childbearing age woman Regular health insurance Primary nonfunction , allograft loss 1 year Previous kidney transplantation History psychiatric , psychologic sensorial disorder prevent patient correctly understand protocol History bilateral arm forearm arteriovenous fistula Counterindication trinitrin Insufficient understand write spoken French language Libertydeprived patient Pregnancy absence contraception childbearing age woman Patient enrol another research protocol within 2 week inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>